BACKGROUND & AIMS: Dietary changes can modulate gut microbiota and interact with cirrhosis. Our prior study demonstrated that microbial diversity was higher in cirrhotics from Turkish vs the USA, which was associated with lower risk of 90-day hospitalizations. We aimed to define gut microbial functional and metabolomic changes to increase insight into benefits of the Mediterranean compared to Western diets. METHODS: In all, 139 Turkish (46 controls/50 compensated/43 decompensated) and 157 American subjects (48 controls/59 compensated/50 decompensated) were studied. Turkish subjects consumed a modified Mediterranean diet with daily fermented milk intake, whereas Americans consumed a Western diet. Predicted gut microbial functionalities and plasma metabolomics were compared between/within countries. Correlation network differences between microbiota and metabolites in cirrhotics from Turkey vs the USA were evaluated. RESULTS: Predicted microbial function showed lower amino acid, bioenergetics and lipid pathways, with functions related to vitamin B, glycan, xenobiotic metabolism, DNA/RNA synthesis, in cirrhotics from Turkey compared to the USA. Plasma metabolomics demonstrated higher relative lactate levels in Turkey vs the USA. The metabolite changes in decompensated cirrhosis, compared to controls, showed similar trends in Turkey and the USA, with reduced lipids and phosphocholines. Phosphocholines were significantly lower in patients hospitalized in 90 days (P = .03). Correlation networks in cirrhotics demonstrated linkage differences between beneficial taxa, Blautia and Oscillispira, and lactate and unsaturated lipids, in Turkey compared to American patients. CONCLUSIONS: A modified Mediterranean diet was associated with altered plasma metabolomics and beneficially alters microbiota functionality and correlations compared to Western diet in cirrhosis. These altered diet-microbial interactions could potentially affect the 90-day hospitalization risk.
BACKGROUND & AIMS: Dietary changes can modulate gut microbiota and interact with cirrhosis. Our prior study demonstrated that microbial diversity was higher in cirrhotics from Turkish vs the USA, which was associated with lower risk of 90-day hospitalizations. We aimed to define gut microbial functional and metabolomic changes to increase insight into benefits of the Mediterranean compared to Western diets. METHODS: In all, 139 Turkish (46 controls/50 compensated/43 decompensated) and 157 American subjects (48 controls/59 compensated/50 decompensated) were studied. Turkish subjects consumed a modified Mediterranean diet with daily fermented milk intake, whereas Americans consumed a Western diet. Predicted gut microbial functionalities and plasma metabolomics were compared between/within countries. Correlation network differences between microbiota and metabolites in cirrhotics from Turkey vs the USA were evaluated. RESULTS: Predicted microbial function showed lower amino acid, bioenergetics and lipid pathways, with functions related to vitamin B, glycan, xenobiotic metabolism, DNA/RNA synthesis, in cirrhotics from Turkey compared to the USA. Plasma metabolomics demonstrated higher relative lactate levels in Turkey vs the USA. The metabolite changes in decompensated cirrhosis, compared to controls, showed similar trends in Turkey and the USA, with reduced lipids and phosphocholines. Phosphocholines were significantly lower in patients hospitalized in 90 days (P = .03). Correlation networks in cirrhotics demonstrated linkage differences between beneficial taxa, Blautia and Oscillispira, and lactate and unsaturated lipids, in Turkey compared to American patients. CONCLUSIONS: A modified Mediterranean diet was associated with altered plasma metabolomics and beneficially alters microbiota functionality and correlations compared to Western diet in cirrhosis. These altered diet-microbial interactions could potentially affect the 90-day hospitalization risk.
Authors: Jasmohan S Bajaj; Chathur Acharya; Andrew Fagan; Melanie B White; Edith Gavis; Douglas M Heuman; Phillip B Hylemon; Michael Fuchs; Puneet Puri; Mitchell L Schubert; Arun J Sanyal; Richard K Sterling; Todd R Stravitz; Mohammad S Siddiqui; Velimir Luketic; Hannah Lee; Masoumeh Sikaroodi; Patrick M Gillevet Journal: Am J Gastroenterol Date: 2018-06-06 Impact factor: 10.864
Authors: Zhaoyu Li; Luis B Agellon; Theresa M Allen; Masato Umeda; Larry Jewell; Andrew Mason; Dennis E Vance Journal: Cell Metab Date: 2006-05 Impact factor: 27.287
Authors: Benjamin Heidrich; Marius Vital; Iris Plumeier; Nico Döscher; Silke Kahl; Janina Kirschner; Szilvia Ziegert; Philipp Solbach; Henrike Lenzen; Andrej Potthoff; Michael Peter Manns; Heiner Wedemeyer; Dietmar Helmut Pieper Journal: Liver Int Date: 2017-06-20 Impact factor: 5.828
Authors: David Ríos-Covián; Patricia Ruas-Madiedo; Abelardo Margolles; Miguel Gueimonde; Clara G de Los Reyes-Gavilán; Nuria Salazar Journal: Front Microbiol Date: 2016-02-17 Impact factor: 5.640
Authors: Mark J W McPhail; Debbie L Shawcross; Matthew R Lewis; Iona Coltart; Elizabeth J Want; Charalambos G Antoniades; Kiril Veselkov; Evangelos Triantafyllou; Vishal Patel; Oltin Pop; Maria Gomez-Romero; Michael Kyriakides; Rabiya Zia; Robin D Abeles; Mary M E Crossey; Wayel Jassem; John O'Grady; Nigel Heaton; Georg Auzinger; William Bernal; Alberto Quaglia; Muireann Coen; Jeremy K Nicholson; Julia A Wendon; Elaine Holmes; Simon D Taylor-Robinson Journal: J Hepatol Date: 2016-01-18 Impact factor: 25.083
Authors: Mario R Álvares-da-Silva; Claudia P Oliveira; Andrew Fagan; Larisse Longo; Rutiane U Thoen; Patricia M Yoshimura Zitelli; Renee M Tanaka Ferreira; Sara Mcgeorge; Amirhossein Shamsaddini; Alberto Q Farias; Masoumeh Sikaroodi; Patrick M Gillevet; Jasmohan S Bajaj Journal: Clin Gastroenterol Hepatol Date: 2021-04-02 Impact factor: 11.382
Authors: Shehnaz K Hussain; Tien S Dong; Vatche Agopian; Joseph R Pisegna; Francisco A Durazo; Pedram Enayati; Vinay Sundaram; Jihane N Benhammou; Mazen Noureddin; Gina Choi; Walid S Ayoub; Venu Lagishetty; David Elashoff; Marc T Goodman; Jonathan P Jacobs Journal: Nutrients Date: 2020-05-13 Impact factor: 5.717